Proprotein Convertase Subtilisin Kexin-9 Inhibitors (PCSK9i) in Atherosclerotic Cardiovascular Disease: Real-World Data Welcome.

J Cardiovasc Pharmacol

Heart and Vascular Center, Division of Cardiology, and Berne Cardiovascular Research Center, School of Medicine, University of Virginia, Charlottesville, VA.

Published: May 2023

Download full-text PDF

Source
http://dx.doi.org/10.1097/FJC.0000000000001411DOI Listing

Publication Analysis

Top Keywords

proprotein convertase
4
convertase subtilisin
4
subtilisin kexin-9
4
kexin-9 inhibitors
4
inhibitors pcsk9i
4
pcsk9i atherosclerotic
4
atherosclerotic cardiovascular
4
cardiovascular disease
4
disease real-world
4
real-world data
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!